91 related articles for article (PubMed ID: 180758)
1. Virus content and effectiveness of foot-and-mouth disease vaccines.
Czelleng F; Sólyom F
Acta Microbiol Acad Sci Hung; 1976; 23(1):77-81. PubMed ID: 180758
[TBL] [Abstract][Full Text] [Related]
2. Attempts at potency testing of foot-and-mouth disease vaccines by evaluation of the complement fixing capacity of eluates.
Bauer K
Dev Biol Stand; 1976; 35():297-300. PubMed ID: 198299
[TBL] [Abstract][Full Text] [Related]
3. Studies on the correct quantitative relations of antigen components in mono-, bi- and trivalent foot-and-mouth disease vaccine preparations.
Sólyom F; Czelleng F
Dev Biol Stand; 1976; 35():289-94. PubMed ID: 198297
[TBL] [Abstract][Full Text] [Related]
4. Determination of antigen content and effectiveness of foor-and-mouth disease vaccines.
Czelleng F; Sólyom F
Dev Biol Stand; 1976; 35():295-6. PubMed ID: 198298
[TBL] [Abstract][Full Text] [Related]
5. An evalutation of some methods of assay of foot-and-mouth disease antigen for vaccines.
Garland AJ; Mowat GN; Fletton B
Dev Biol Stand; 1976; 35():323-32. PubMed ID: 198302
[TBL] [Abstract][Full Text] [Related]
6. Comparison of laboratory techniques for the evaluation of the antigenic potency of foot-and-mouth disease virus cultures and vaccines.
Terpstra C; Frenkel S; Straver PJ; Barteling SJ; van Bekkum JG
Dev Biol Stand; 1976; 35():333-42. PubMed ID: 198304
[No Abstract] [Full Text] [Related]
7. A simple quantitative microtest for determination of the complement fixing activity of foot-and-mouth disease virus.
Petr G; Láznicka F
Acta Virol; 1972 Mar; 16(2):133-40. PubMed ID: 4401070
[No Abstract] [Full Text] [Related]
8. [Study of the indirect complement fixation test for use in the differentiation of foot-and-mouth disease viruses and the determination of immunity].
Tekerlekov P; Mitev G; Nikolova E
Vet Med Nauki; 1975; 12(6):28-34. PubMed ID: 179191
[TBL] [Abstract][Full Text] [Related]
9. A micro-enzyme-lavelled immunosorbent assay (MICORELISA) for the detection of foot-and-mouth disease virus antigen and antibody.
Rai A; Lahiri DK
Acta Virol; 1981 Jan; 25(1):49-52. PubMed ID: 6112866
[TBL] [Abstract][Full Text] [Related]
10. The use of serum neutralizing antibody assay for the determination of the potency of foot and mouth disease (FMD) vaccines in cattle.
Pay TW; Hingley PJ
Dev Biol Stand; 1986; 64():153-61. PubMed ID: 3025036
[TBL] [Abstract][Full Text] [Related]
11. [Demonstration of antibody-synthesizing cells in mice and swine by means of local hemolysis in gel following immunization with foot-and-mouth disease virus and vaccine].
Wittmann G; Reda I
Zentralbl Bakteriol Orig A; 1974; 227(1-4):420-5. PubMed ID: 4154623
[No Abstract] [Full Text] [Related]
12. [The effectiveness of foot-and-mouth disease vaccines in Switzerland. II. Stability problems].
Ackermann M; Müller HK; Bruckner L; Kihm U
Schweiz Arch Tierheilkd; 1989; 131(7):389-95. PubMed ID: 2552580
[TBL] [Abstract][Full Text] [Related]
13. [Development of a method for the quantitative determination of the immunizing antigen (140S) of the foot-and-mouth disease virus].
Tekerlekov P; Vasileva L; Nikolova E; Veleva E
Vet Med Nauki; 1985; 22(9):10-9. PubMed ID: 3002008
[TBL] [Abstract][Full Text] [Related]
14. Reduction of animal usage in the control of foot-and-mouth disease vaccines.
Strobbe R
Dev Biol Stand; 1986; 64():163-7. PubMed ID: 3025037
[TBL] [Abstract][Full Text] [Related]
15. Proceedings: Quantitative assay of the immunizing dose of monovalent vaccines against foot-and-mouth disease prepared from the virus propagated on cattle tongue mucosa and in culture after Frenkel.
Wiśniewski J; Kobusiewicz T; Szkilnik S; Baranowski C; Jankowska J; Labecka W
Acta Microbiol Pol A; 1974; 6(1):131. PubMed ID: 4364054
[No Abstract] [Full Text] [Related]
16. Serological differentiation of foot-and-mouth disease virus strains in relation to selection of suitable vaccine viruses.
Rweyemamu MM; Pay TW; Parker MJ
Dev Biol Stand; 1976; 35():205-4. PubMed ID: 198288
[No Abstract] [Full Text] [Related]
17. [Comparatve serological and immunological study of strains of foot-and-mouth disease virus type "O" isolated in Europe between 1963 and 1966].
Moosbrugger GA; Leunen J; Mackowiak C; Fontaine J; Roumiantzeff M
Bull Off Int Epizoot; 1967; 67(5):711-29. PubMed ID: 4303616
[No Abstract] [Full Text] [Related]
18. [Identification of epizootic strains of foot-and-mouth disease virus in the U.S.S.R].
Sobko AI; Sokolov LN; Gritsenko AI; Nesterova IF; Prokhorov VN; Tcherniaev IA; Rodionov VI
Bull Off Int Epizoot; 1972; 77(5):913-27. PubMed ID: 4350007
[No Abstract] [Full Text] [Related]
19. Differentiation of type A foot-and-mouth disease virus subtypes by double- and radial-immunodiffusion analysis.
Lobo CA; Cowan KM; Trautman R; Hanson RP
Am J Vet Res; 1974 Aug; 35(8):1121-6. PubMed ID: 4368590
[No Abstract] [Full Text] [Related]
20. Inactivated-concentrated virus antigen for indirect complement fixation test of foot-and-mouth disease.
Sakaki K; Suphavilai P; Chandarkeo T
Natl Inst Anim Health Q (Tokyo); 1978; 18(3-4):128-34. PubMed ID: 216926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
